Mistake 4: not adjusting expectations for dose escalation periods Every dose increase brings temporary water retention, digestive changes, and altered eating patterns that can mask ongoing fat loss
doi: 10.1038/s41467-021-22938-y 100 ZhaoLZhangFDingXWuGLamYYWangXet al
Zepbounds approval for moderate to severe OSA in adults with obesity is based on two randomized, double-blind, placebo-controlled studies of 469 adults without type 2 diabetes
The FDA-approved prescribing information recommends gradual dose titration to minimize gastrointestinal side effects
Wang X, Sun K, Dong J, Ge Y, Liu H, Jin X et al (2025) Carrier-free nanoparticles based on natural products trigger dual synergy and attenuation for enhanced phototherapy of liver cancer